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Tuberculosis makes it onto the international political agenda 
for health...finally
The fact that more than 10 million people fall ill with 
tuberculosis annually, and that 5000 die of it every 
day, including about 1000 because of HIV-associated 
infection, speaks to the gravity of the global problem 
of tuberculosis. Tuberculosis has many other dubious 
distinctions that merit attention: it is one of the oldest 
diseases known to mankind and yet one of the top ten 
global causes of death today, the top infectious cause 
of death worldwide, the top killer of people with HIV 
infection, and a top cause of death due to antimicrobial-
resistant infections.1 Bearing this in mind, investing 
in the fight against tuberculosis is a “no brainer” 
development target, according to The Economist and 
the Copenhagen Consensus, given the benefits gained 
per dollar spent.2 Countries have committed, as part 
of the WHO’s End TB Strategy and the Sustainable 
Development Goals (SDGs), to ending the tuberculosis 
epidemic by 2030.3,4 The Stop TB Partnership’s Global 
Plan to End TB, 2016–2020, laid out the estimated 
financing needs for the first 5 years in implementing the 
End TB Strategy.5 Yet in 2016, WHO reported that the 
world was failing to accelerate actions to meet the first 
milestones towards these targets.
At the end of 2016, there finally seemed to be a swell 
of political recognition of the problem, in view of the 
dire facts and growing vocal demand from people 
affected by tuberculosis. First, WHO and the Russian 
Federation decided to hold the very first WHO Global 
Ministerial Conference on Ending TB (Nov 16–17, 2017) 
to stimulate action and commitments. Second, the UN 
General Assembly announced the first ever high-level 
meeting on the fight against tuberculosis in 2018.6 
Third, in July, 2017, the G20 leaders recognised that 
acting on priority pathogens, including tuberculosis, is 
a crucial part of global efforts to combat antimicrobial 
resistance. Fourth, at the meeting of the Brazil, Russia, 
India, China, and South Africa (BRICS) leaders in 
September, 2017, these countries committed to combat 
tuberculosis together, including advancing tuberculosis 
research. There is a strong foundation on which this 
work is building: between 2000 and 2016, tuberculosis 
treatment alone saved 53 million lives, including those 
of people with HIV.
However, there are profound weaknesses that inhibit 
acceleration of these movements. Weak health systems 
are still far from providing universal coverage without 
financial hardship for high-quality services, including use 
of new tools for tuberculosis care and, more urgently, 
for multidrug-resistant tuberculosis, leaving more than 
a third of all tuberculosis cases unreported. There is a 
dearth of innovative approaches that enable reaching 
the high-risk groups and susceptible populations. There 
is also a paucity of new and better tools for tuberculosis 
care and prevention: point-of-care diagnostics, new 
drugs, shorter and better treatment regimens, and 
safe and effective tuberculosis vaccines. Finally, there 
is no truly multisectoral tuberculosis response, which 
is essential to address the drivers and determinants of 
the epidemic.
The latest global burden of disease assessment 
measuring progress on health-related SDGs concludes 
that tuberculosis is one of the health challenges for which 
dramatic acceleration of progress is most needed.7 Such 
urgent acceleration of efforts and investments is possible 
considering recent changes in global political economy: 
half of the countries with high tuberculosis incidence 
that were classified as low-income in 2000 are now in 
the middle-income category, and more countries are 
expected to join by 2020.8 The five BRICS countries bear 
about 45% of the world’s burden of tuberculosis and 
more than 60% of the multidrug-resistant tuberculosis 
burden.9 BRICS and other middle-income countries with 
growing economies could ensure that domestic resources 
are mobilised and sustained to finance their responses 
to tuberculosis. Ending the global tuberculosis epidemic 
also requires parallel and substantial progress on health-
related and other SDGs. Within the health-related 
SDG3 targets, universal health coverage and controlling 
the epidemics of HIV, diabetes, alcohol-use disorders, 
and tobacco smoking need to be addressed. The drivers 
and determinants of the tuberculosis epidemic and 
the direct risk factors for tuberculosis will, however, 
need action on other, non-health-related SDGs. These 
include addressing poverty and social protection (SDG1), 
hunger (SDG2), indoor air pollution (SDG7), working 
and living conditions (SDG8), inequalities (SDG10), 
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and urban slums (SDG11). The triple feat of reaching 
more people who need care today, broadening actions to 
prevent tuberculosis, and investing in research to deliver 
innovations means that leaders from within and beyond 
government need to act in a coordinated fashion.
There are at least four clear expectations from the health 
ministers and all partners gathering at the ministerial 
conference in Moscow. First, speed up universal coverage 
of care and prevention for tuberculosis, HIV-associated 
tuberculosis, and multidrug-resistant tuberculosis in 
the context of the global agendas of antimicrobial 
resistance, health security, and SDGs, while ensuring that 
equity, ethics, and human rights are recognised as urgent 
concerns and are protected and promoted. Second, enable 
sufficient and sustained financing for the full response 
from strengthened domestic and external sources. Third, 
urgently increase coordinated investments in research 
and innovations. Finally, and most importantly, to drive 
real action built on written commitments, a multisectoral 
accountability framework needs to be prepared and 
adhered to. This framework needs to encompass all 
dimensions of the tuberculosis response and enable not 
just measuring progress towards ending tuberculosis, but 
also timely reviewing of results through government and 
civil society accountability mechanisms at national and 
global levels, as well as taking corrective actions.
WHO Member States, the Stop TB Partnership, civil 
society, and other stakeholders are working to make 
the most of the historic UN General Assembly high-level 
meeting on tuberculosis in 2018. The WHO Ministerial 
Conference in November, 2017, should provide ministers 
of health and their heads of state with essential building 
blocks towards achieving revolutionary commitments in 
2018, and beyond.
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